Literature DB >> 23277420

The management of ocular allergy in community pharmacies in the United Kingdom.

Paramdeep Bilkhu1, James S Wolffsohn, Deanna Taylor, Emma Gibson, Bhavik Hirani, Shehzad A Naroo.   

Abstract

BACKGROUND: Ocular allergies frequently present in pharmacy practices. However, research into the actual management of ocular allergy in pharmacies is lacking.
OBJECTIVE: To determine and quantify history and symptom questioning of a patient with presumed allergic conjunctivitis and management strategies employed by pharmacy staff in the UK.
METHOD: A mystery shopper technique was used to simulate an episode of allergic conjunctivitis in 100 community pharmacies across the UK.
RESULTS: The mean number of questions asked by pharmacy staff to the patient was 3.5 ± 2.6, with a range of 0-10. The most common question was whether the patient had a history of allergies (45 %).Ninety-one percent advised on treatment, with the remaining 9 % directly referring to the patient's general practitioner (n = 4) or pharmacist(n = 4), but only two to their optometrist. The most common treatment suggested was sodium cromoglycate 2 % (50 %). However, many pharmacies advising treatment did not ask the patient's age (37 %), if they wore contact lenses (43 %), or gave dosage advice (43 %). Only 5 % of pharmacies advised follow up and 14 % suggested visiting a general practitioner and 1 % an optometrist if symptoms did not resolve with treatment.
CONCLUSION: There is a need for improved ophthalmological training for pharmacy staff with respect to the management of allergic conjunctivitis.

Entities:  

Mesh:

Year:  2013        PMID: 23277420     DOI: 10.1007/s11096-012-9742-z

Source DB:  PubMed          Journal:  Int J Clin Pharm


  7 in total

1.  Otrivine-antistin-pupil, corneal and conjunctival responses to topical administration.

Authors:  D R Trew; L A Wright; S E Smith
Journal:  Eye (Lond)       Date:  1989       Impact factor: 3.775

2.  Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial.

Authors:  J Miller; E H Wolf
Journal:  Ann Allergy       Date:  1975-08

Review 3.  A review of non-pharmacological and pharmacological management of seasonal and perennial allergic conjunctivitis.

Authors:  Paramdeep S Bilkhu; James S Wolffsohn; Shehzad A Naroo
Journal:  Cont Lens Anterior Eye       Date:  2011-09-16       Impact factor: 3.077

Review 4.  Ocular allergy treatment.

Authors:  Leonard Bielory
Journal:  Immunol Allergy Clin North Am       Date:  2008-02       Impact factor: 3.479

Review 5.  Ocular allergy overview.

Authors:  Leonard Bielory
Journal:  Immunol Allergy Clin North Am       Date:  2008-02       Impact factor: 3.479

6.  Mystery shopping in health service evaluation.

Authors:  Helen Moriarty; Deborah McLeod; Anthony Dowell
Journal:  Br J Gen Pract       Date:  2003-12       Impact factor: 5.386

7.  Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.

Authors:  G T Fahy; D L Easty; L M Collum; A Benedict-Smith; M Hillery; D G Parsons
Journal:  Eur J Ophthalmol       Date:  1992 Jul-Sep       Impact factor: 1.922

  7 in total
  3 in total

Review 1.  Is there potential for the future provision of triage services in community pharmacy?

Authors:  Louise E Curley; Janice Moody; Rukshar Gobarani; Trudi Aspden; Maree Jensen; Maureen McDonald; John Shaw; Janie Sheridan
Journal:  J Pharm Policy Pract       Date:  2016-09-29

Review 2.  Role of community pharmacists in patients' self-care and self-medication.

Authors:  Paul Rutter
Journal:  Integr Pharm Res Pract       Date:  2015-06-24

3.  Pharmacist Compliance With Therapeutic Guidelines on Diagnosis and Treatment Provision.

Authors:  Harriet Smith; Stephen Whyte; Ho Fai Chan; Gregory Kyle; Esther T L Lau; Lisa M Nissen; Benno Torgler; Uwe Dulleck
Journal:  JAMA Netw Open       Date:  2019-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.